Late last week, President Donald Trump sent letters to 17 pharmaceutical companies pressing them to deliver on his May ...

Patent Bots, creator of AI-enabled software for patent attorneys, is well known for its annual Patent Quality Rankings. The ...

In the latest slew of Director Discretionary Denial decisions issued last week by the U.S. Patent and Trademark Office (USPTO), Acting USPTO Director Coke Morgan Stewart largely delivered wins for ...

Last week, reports surfaced that spokespeople from the European Commission had confirmed the official withdrawal of ...

In a recent letter sent to U.S. Trade Representative Jamieson Greer and Secretary of Commerce Howard Lutnick,18 Republican ...

A recent Statement of Interest filed by the U.S. government includes several statements potentially providing insight into ...

Under current law, only natural persons can be inventors on a patent. But as AI systems become more sophisticated and ...

The U.S. District Court for the District of Columbia on Wednesday denied Register of Copyrights Shira Perlmutter’s request ...

On Monday, the Federal Circuit issued a precedential ruling in Jiaxing Super Lighting Electric Appliance v. CH Lighting ...

Techson IP advances its GenAI patent monetization leadership with the launch of its Limestone|Report Partnership Program for ...

A full-time, fully remote role is available at Thompson Patent Law for an experienced Associate Patent Attorney with a ...

The cost of prescription pharmaceuticals is higher in the United States than anywhere else in the world, and many in the United States—including President Trump—are fed up with this imbalance. There ...